PATENT CLAIM ANALYSIS

Application Number: 16090664
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "457000"]

Abstract:
There is provided herein a pharmaceutical formulation having one or more component comprising valproic acid (VPA) and/or a pharmaceutically acceptable salt thereof; and one or more secondary acid, and optionally comprising one or more pharmaceutically acceptable excipient. There is also provided uses of such formulations.

Claim (Index 20):
The pharmaceutical formulation for use of  claim 19 , wherein the treatment or prevention is in a patient at increased risk of developing a pathological condition associated with excess fibrin deposition and/or thrombus formation.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 97.0
- Lexical Diversity: 1.45714
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13143498', '11897940', '14841428', '14710453', '14704836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7279927405243067
- 35 USC 102 Novelty (BERT): 0.5188809929371335
- Combined Prediction Score: 0.7070815657655893
- Mean Citation Score: 219.488626
- Max Citation Score: 227.57492
- Similarity Product: 121.6550456887722

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test